Frequent activation of mammalian target of rapamycin in primary lung adenocarcinoma and preinvasive lesion

作者: Younghye Kim , Hoiseon Jeong , Aeree Kim , Han Kyeom Kim , Bong Kyung Shin

DOI: 10.1111/J.1755-9294.2011.01108.X

关键词:

摘要: Background and aim: The mammalian target of rapamycin (mTOR) pathway is important for cell survival, growth proliferation may be involved in the histological progression lung adenocarcinoma (AC). Methods: We compared expression mTOR signal molecules, i.e., phosphorylated m-TOR (p-mTOR), phosphatase tensin homolog deleted on chromosome ten (PTEN), epidermal factor receptor (EGFR), cyclin D1, among AC, situ (AIS) including both pure bronchioloalveolar carcinoma (BAC) peripheral BAC-like lesions around invasive carcinoma, atypical adenomatous hyperplasia (AAH), normal parenchyma surrounding tumor by immunohistochemistry. protein was also correlated with patients’ clinicopathological data smoking history, stage at diagnosis, recurrence survival. Results: Intermediate or strong immunoreactivity p-mTOR seen 84.1% AC 90.2% AIS. Partial complete loss PTEN demonstrated 88.8% 30.4% A significant trend increasing EGFR, PTEN, p53 Ki-67 labeling index were observed from AAH to through Expression associated status. Conclusions: Activation can occur various stimuli an early event carcinogenesis sex status patient.

参考文章(29)
Masayuki Noguchi, Yukío Shimosato, The development and progression of adenocarcinoma of the lung. Cancer treatment and research. ,vol. 72, pp. 131- 142 ,(1994) , 10.1007/978-1-4615-2630-8_6
Yoh Dobashi, Shioto Suzuki, Hirochika Matsubara, Maiko Kimura, Shunsuke Endo, Akishi Ooi, Critical and diverse involvement of Akt/mammalian target of rapamycin signaling in human lung carcinomas Cancer. ,vol. 115, pp. 107- 118 ,(2009) , 10.1002/CNCR.23996
U Pastorino, S Andreola, E Tagliabue, F Pezzella, M Incarbone, G Sozzi, M Buyse, S Menard, M Pierotti, F Rilke, Immunocytochemical markers in stage I lung cancer: relevance to prognosis. Journal of Clinical Oncology. ,vol. 15, pp. 2858- 2865 ,(1997) , 10.1200/JCO.1997.15.8.2858
Shioto Suzuki, Yoh Dobashi, Hiroyuki Sakurai, Keiichi Nishikawa, Mitsuhiko Hanawa, Akishi Ooi, Protein Overexpression and Gene Amplification of Epidermal Growth Factor Receptor in Nonsmall Cell Lung Carcinomas An Immunohistochemical and Fluorescence in Situ Hybridization Study Cancer. ,vol. 103, pp. 1265- 1273 ,(2005) , 10.1002/CNCR.20909
A David, M David, An expanding role for mTOR in cancer Trends in Molecular Medicine. ,vol. 11, pp. 353- 361 ,(2005) , 10.1016/J.MOLMED.2005.06.007
D. Maxwell Parkin, Freddie Bray, Jacques Ferlay, Paola Pisani, Estimating the world cancer burden: Globocan 2000 International Journal of Cancer. ,vol. 94, pp. 153- 156 ,(2001) , 10.1002/IJC.1440
Thomas A. D'Amico, MD, Marga Massey, MD, James E. Herndon II, PhD, Mary-Beth Moore, David H. Harpole, A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers The Journal of Thoracic and Cardiovascular Surgery. ,vol. 117, pp. 736- 743 ,(1999) , 10.1016/S0022-5223(99)70294-1
Jungsuk An, Hoiseon Jeong, Youngseok Lee, Sang Uk Woo, Jae Hong Seo, Aeree Kim, Phosphorylated Akt and Phosphorylated mTOR Expression in Breast Invasive Carcinomas: Analysis of 530 Cases Journal of Breast Cancer. ,vol. 13, pp. 337- 348 ,(2010) , 10.4048/JBC.2010.13.4.337
Steven Belinsky, John Brognard, Sandra M. Swain, Curtis Harris, Amy S. Clark, Phillip A. Dennis, Ilona R. Linnoila, Xiaowei Yang, Kip A. West, Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells Journal of Clinical Investigation. ,vol. 111, pp. 81- 90 ,(2003) , 10.1172/JCI16147